Podcast
Optimizing IPF Care Through Improvements in Diagnosis, Treatment, and Shared Decision-Making
Release Date: October 13, 2021
Expiration Date: October 12, 2022
Not certified for credit.
Begin »
Program Overview
Program Description
In this podcast, Corinne R. Young, MSN, FNP-C, FCCP, provides a summary of key points addressed by expert faculty during a live webinar on optimizing idiopathic pulmonary fibrosis (IPF) care focusing on timely diagnosis, proper referrals, and pharmacologic and nonpharmacologic treatment options. The discussion concludes with a review of the importance of shared decision-making when treating patients with IPF.
In Partnership With the Association of Pulmonary Advanced Practice Providers
Format
Podcast
Learning Objectives
After completing this activity, participants should be better able to:
- Identify the signs and symptoms of IPF to make an accurate diagnosis and referral earlier in the course of disease
- Devise a treatment plan that incorporates current treatment guidelines and therapies as well as management of comorbidities and risk factors
- Apply effective communication and shared decision-making skills during patient visits
Target Audience
NPs and PAs
Faculty
Corinne R. Young, MSN, FNP-C
- Founder and President
- Association of Pulmonary Advanced Practice Providers
- Pulmonary Nurse Practitioner
- Colorado Springs, Colorado
Details
This activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Genentech, a member of the Roche Group.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.
All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Ms Young has no relevant financial relationships to disclose.
None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose.
For Practicing Clinicians Exchange general information, contact pce@practicingclinicians.com.
© 2022 Practicing Clinicians Exchange. All Rights Reserved. 102621BI-2